Skip to main content

Table 1 Intratumoral EpCAM expression in all study patients

From: High EpCAM expression is linked to proliferation and lauren classification in gastric cancer

EpCAM expression

 

0

1+

2+

3+

Σ

patients

37 (23%)

52 (32%)

27 (17%)

47 (29%)

163

Primary tumor

     

pT1

3 (14%)

10 (48%)

4 (19%)

4 (19%)

21

pT2

22 (26%)

25 (29%)

15 (17%)

24 (28%)

86

pT3

10 (21%)

13 (27%)

7 (15%)

18 (38%)

48

pT4

2 (25%)

4 (50%)

1 (13%)

1 (13%)

8

Lymph node status

     

pN0

8 (20%)

13 (32%)

10 (24%)

10 (24%)

41

pN1

10 (19%)

19 (35%)

8 (15%)

17 (31%)

54

pN2

8 (29%)

10 (36%)

4 (14%)

6 (21%)

28

pN3

11 (28%)

10 (26%)

5 (13%)

13 (33%)

39

Tumor grade

     

G1

1 (50%)

0 (0%)

1 (50%)

0 (0%)

2

G2

5 (14%)

11 (31%)

8 (22%)

12 (33%)

36

G3

30 (25%)

40 (33%)

18 (15%)

34 (28%)

122

G4

1 (33%)

1 (33%)

0 (0%)

1 (33%)

3

Laurén classification

     

diffuse

20 (33%)

15 (25%)

9 (15%)

17 (28%)

61

intestinal

8 (13%)

21 (34%)

13 (21%)

20 (32%)

62

mixed

7 (22%)

12 (38%)

4 (13%)

9 (28%)

32

not classified

2 (25%)

4 (50%)

1 (13%)

1 (13%)

8